Daniel Gehrlach

Daniel Gehrlach

Company: HMNC Brain Health

Job title: Director, Biomarkers

Seminars:

Bringing Precision to Psychiatry: Pioneering Genetic CDx-Use in Major Depressive Disorder 2:00 pm

The Unmet Need in Psychiatry: Psychiatry has lagged behind oncology and immunology in adopting CDx, despite the clear potential to address the biological heterogeneity of disorders like MDD Our Innovative CDx Platform anticifyâ„¢: Using statistical genetics, we’ve developed tools to stratify MDD patients into biologically distinct subtypes, enabling personalised treatment strategies Clinical Validation of CDx…Read more

day: Day 2 - Track A (2)

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.